We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-23.25%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$358M
AUM Growth
-$182M
Cap. Flow
-$93.9M
Cap. Flow %
-26.23%
Top 10 Hldgs %
31.98%
Holding
756
New
76
Increased
136
Reduced
196
Closed
54

Sector Composition

Rank Sector Weight
1 Healthcare 11.28%
2 Technology 9.96%
3 Financials 8.31%
4 Consumer Discretionary 6.97%
5 Communication Services 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KGC icon
451
Kinross Gold
KGC
$28.3B
$4.84K ﹤0.01%
1,217
-143,968
-99% -$696K
TRNO icon
452
Terreno Realty
TRNO
$7.7B
$4.76K ﹤0.01%
92
NUGT icon
453
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$875M
$4.76K ﹤0.01%
140
-60
-30% -$7.92K
CTSH icon
454
Cognizant
CTSH
$22.3B
$4.65K ﹤0.01%
100
EPHE icon
455
iShares MSCI Philippines ETF
EPHE
$130M
$4.56K ﹤0.01%
198
-31,248
-99% -$924K
NRG icon
456
NRG Energy
NRG
$29.1B
$4.53K ﹤0.01%
166
-16,512
-99% -$569K
EEM icon
457
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.4B
$4.5K ﹤0.01%
1,500
GS icon
458
Goldman Sachs
GS
$308B
$4.17K ﹤0.01%
27
BIIB icon
459
Biogen
BIIB
$29.9B
$4.11K ﹤0.01%
13
BOTZ icon
460
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.18B
$4.1K ﹤0.01%
226
-9,674
-98% -$199K
SHY icon
461
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$4.07K ﹤0.01%
47
NBIX icon
462
Neurocrine Biosciences
NBIX
$17.7B
$4.07K ﹤0.01%
47
HEXO
463
DELISTED
HEXO Corp. Common Shares
HEXO
$4.03K ﹤0.01%
89
MDLZ icon
464
Mondelez International
MDLZ
$77.8B
$3.96K ﹤0.01%
79
TWLO icon
465
Twilio
TWLO
$29.5B
$3.94K ﹤0.01%
44
ALGN icon
466
Align Technology
ALGN
$12.1B
$3.83K ﹤0.01%
22
SPHD icon
467
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.38B
$3.69K ﹤0.01%
123
FINX icon
468
Global X FinTech ETF
FINX
$169M
$3.65K ﹤0.01%
151
-9,349
-98% -$278K
WMGI
469
DELISTED
Wright Medical Group Inc
WMGI
$3.61K ﹤0.01%
126
AKBA icon
470
Akebia Therapeutics
AKBA
$341M
$3.57K ﹤0.01%
471
LCII icon
471
LCI Industries
LCII
$2.51B
$3.48K ﹤0.01%
52
IQV icon
472
IQVIA
IQV
$35.2B
$3.45K ﹤0.01%
32
+20
+167% +$2.86K
VRN
473
DELISTED
Veren
VRN
$3.43K ﹤0.01%
4,482
CYBR
474
DELISTED
CyberArk
CYBR
$3.42K ﹤0.01%
40
-1,460
-97% -$168K
VAC icon
475
Marriott Vacations Worldwide
VAC
$3.3B
$3.11K ﹤0.01%
56

Similar funds

Exane Derivatives's Q1 2020 Portfolio in Review

As of Q1 2020, Exane Derivatives held 756 positions worth $358M, down 34% from $540M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Exane Derivatives withdrew a net $93.9M in Q1 2020, closing 54 positions and reducing 196 holdings. Its most notable exit was Ferrari, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 5.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Exane Derivatives opened a new position in VanEck Oil Services ETF worth $2.8M.

  • Exane Derivatives's largest Q1 2020 buy was VanEck Oil Services ETF: 34,775 shares worth $2.8M.
  • Exane Derivatives added most to iShares MSCI Poland ETF in Q1 2020, an estimated $9.75M increase.
  • Exane Derivatives's biggest Q1 2020 reduction was UBS Group, cutting an estimated $24.1M.
  • Exane Derivatives fully exited Ferrari in Q1 2020, selling an estimated $13.3M.
  • Exane Derivatives's ten largest holdings make up 32% of its $358M portfolio in Q1 2020.
  • Exane Derivatives opened 76 new positions and closed 54 in Q1 2020.
  • Exane Derivatives's portfolio value fell 34% quarter-over-quarter to $358M.

Based on Exane Derivatives's 13F filing for Q1 2020, filed 17 Apr 2020.